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d hostinAbstract Background: Unsuspected morbidity and mortality in cerebrovascular stroke (CVS)
patients remain a serious issue in critical medicine ﬁeld. Patients with CVS are at increased risk
of developing cardiac complications which explains the high morbidity and mortality rates among
those patients. We examined the predictive value of cardiac troponin T (CTNT) in assessing myo-
cardial injury and cardiac dysfunction in ischemic and hemorrhagic CVS.
Methods: One hundred and twenty patients with acute CVS (78 with infarction, 42 with hemor-
rhage) conﬁrmed by brain CT scan were enrolled. CTNT assay was done within 24 h of stroke onset
at 0, 12, and 24 h. Levels equal to or more than 0.1 ng/mL were deemed high. Echocardiographic
evaluation was done at 3rd to 5th day for new segmental wall motion abnormalities (SWMA).
Twelve lead electrocardiograms (ECGs) were done on day 1, 2, 3, and 5 from stroke onset. ST seg-
ment elevation or depressionP1 mm, and/or T wave ﬂattening or inversion in three leads were con-
sidered signiﬁcant. Patients with history of CAD, resting ST-T wave changes were excluded.
Results: CTNT was elevated in 24 patients (20%), 12 patients with infarction (15.3%), and 12 with
hemorrhage (28.5%), P> 0.05. Abnormal ECGs were observed in 50 cases (12 had ST deviation, 38
had T wave changes). All troponin +ve patients showed abnormal ECG (100%), compared to only
26 patients out of the troponinve patients (27%) (P< 0.01). ST deviation occurred in 10 troponin
+ve patients (41.6%), two troponin ve patients (2.08%), (P< 0.01). T wave changes occurred in
14 troponin +ve patients (58.3%), 24 troponin ve patients (25%), (P< 0.05). Resting SWMA
were observed in 24 cases, all of which had +ve troponin, none of the troponin ve patients showed
SWMA (100% sensitivity, speciﬁcity, positive and negative predictive values) P< 0.001.
Conclusions: Myocardial injury is not uncommon in patients with CVS. Silent ST-T wave changes
and new resting SWMA are possible complications. We demonstrated highly signiﬁcant correlation
between positive troponin T and myocardial injury in these patients.
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136 M. Amin et al.1. Introduction
The need for multidisciplinary evaluation of patients with
stroke has recently been established.1 The role of cardiologist
is highly relevant, given the multiple interactions between car-
diovascular and cerebrovascular disease.2 There are several
reasons why the cardiologist should be closely involved in
the management of patients with cerebrovascular stroke
(CVS) or transient ischemic attacks (TIA).3 Ischemic stroke
and TIA have a cardioembolic origin in 20–25% of cases4
and over 50% of patients with cerebrovascular disease may
have coexisting coronary artery disease.5 Among stroke survi-
vors, after the ﬁrst year, the risk of death from non-stroke car-
diovascular disease exceeds that of stroke.6
Unsuspected morbidity and mortality in cerebral stroke pa-
tients remain a serious issue in critical medicine ﬁeld. Patients
with cerebral stroke are at increased risk of developing cardiac
complications which explains the high morbidity and mortality
rates among stroke patients.7 Neurogenic inﬂuence on the
heart is a newly well known phenomenon with pathological
proof of myocytolysis and electrophysiological proof of car-
diac conduction abnormalities.8
Biochemical markers are powerful and sensitive predictors
of cardiac damage among cerebral stroke patients, so estab-
lishing correct prediction for high incidence of mortality and
sudden deaths among stroke cases.9 Elevated activity of sym-
pathetic nervous system and elevated systemic catecholamine
levels induced by cerebral stroke are responsible for myocar-
dial damage.10
We aimed at investigating the predictive value of cardiac
troponin T (CTNT) in assessing myocardial injury and cardiac
dysfunction in different types of stroke (ischemic and hemor-
rhagic) and its relationship to stroke size and volume.
2. Patients and methods
2.1. Study population
One hundred and twenty consecutive patients with acute
stroke conﬁrmed by CT scan of the brain, aged between 40
and 70 years, were included in this study which was conducted
in the cardiology department of Police Authority Hospital in
cooperation with neuropsychiatry department of the same hos-
pital. Patients with the history of CAD, patients with resting
ST-T wave changes (LBBB, WPW syndrome and patients on
digitalis therapy), and patients with any condition that may
elevate CTNT level (pulmonary embolism, congestive heart
failure, cardiac trauma, renal impairment and myocarditis)
were excluded from the study.
2.2. Methods
Careful history analysis including history of risk factors (e.g.:
hypertension, smoking, diabetes mellitus, and dyslipedemia),
general clinical assessment and physical examination with de-
tailed cardiac and neurological evaluation was done for all
patients.
2.2.1. Electrocardiography
Twelve lead ECG was done on 1st, 2nd, 3rd, 5th day after
stroke. ST-T changes were considered signiﬁcant if the patientfulﬁlled at least one of the following criteria: more than 1 mm
elevation or depression of ST segment and/or T wave inversion
or ﬂattening at least in three leads.11
2.2.2. Echocardiography
Standard echocardiographic evaluation was performed on
Vingmed CFM 800 system with a 2.5 MHz transducer on
admission, then on the 3rd and 5th day. Standard views were
used to assess resting segmental wall motion abnormalities
(SWMA) as deﬁned by the American society of echocardiogra-
phy.12 Myocardial dysfunction was diagnosed in the presence
of new segmental wall motion abnormalities.13 All examina-
tions were performed by one experienced echocardiographer
who was blinded to CT results.
2.2.3. Biochemical markers
Troponin T assay was done within 24 h of stroke onset at 0, 12
and 24 h. Serum CTNT concentration was measured using the
elecsys 2010 immunoassay system (Roche-Boehringer, Mann-
heim). Concentrations equal to or more than 0.1 ng/mL were
deemed high.14 CPK, CK MB, LDH were also evaluated.
2.2.4. Brain CT scan
Using the CT images, the volume and the largest diameter of
the cerebral lesions were calculated. Lesions were classiﬁed
according to their largest diameter into: small lesions
<1.5 cm, moderate lesions 1.5–3 cm, and large lesions
>3 cm.15 Mild and moderate cases were combined in one
group to ease further statistical comparisons.
An informed consent was given by all patients (or by close
relative) and the study was approved by the local committee.
2.3. Statistical analysis
Data were collected, veriﬁed, revised, and edited on a personal
computer; then statistically analyzed using SPSS statistical
package version 12 and Microsoft excel 2003. The following
tests were performed: mean and standard deviation, Chi
square test (v2), ANAVA for analysis of variance, post Hoc
test to detect least signiﬁcant difference (LSD), and Student t
test. P value <0.05 was considered, while P value <0.01
was considered highly signiﬁcant.
3. Results
3.1. Demographic data and risk factors
This study included 120 patients: 70 (58.3%) males and 50
(41.7%) females, with a mean age of 60.25 ± 8.56 years.
Hypertension was the most prevalent risk factor among the
study group, followed by smoking, dyslipedemia, and diabetes
mellitus, respectively (Table 1).
3.1.1. CT brain
Seventy-eight patients (65%) out of the population study
presented with cerebral infarction, while 21 (25%) patients pre-
sented with cerebral hemorrhage (35%). Volume of the lesion
ranged from 3 to 128 cm3 with a mean of 42.35 ± 30.18 cm3.
Diameter of cerebral lesion ranged from 1 to 5 cm with a mean
of 2.73 ± 0.82 cm. Twenty lesions (16.7%) were large lesions
(>3 cm).
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CKMB was elevated in 32 patients (26.7%) with a mean value
of 25.88 ± 20.32 IU/L. Troponin T was elevated in 24 patients
(20%) with a mean value of 0.14 ± 0.13 ng/mL.
3.1.3. Electrocardiographic and echocardiographic abnormalities
New ST-T wave changes were observed in 50 patients (41.6%):
38 (31.6%) patients showed T wave changes, while 12 (10%)
patients showed ST deviation. Arrhythmias and conduction
defects were observed in seven cases. Resting SWMA were ob-
served in 24 cases (Table 2).
According to CTNT levels, patients were classiﬁed into tro-
ponin +ve patients (n= 24) and troponin ve (n= 96) pa-
tients for further analysis.
3.2. Comparison between troponin +ve patients and troponin
ve patients
3.2.1. Regarding sex and risk factors
Hypertension and dyslipedemia were more prevalent in the
troponin +ve group with no differences regarding gender or
other risk factors (Table 3).
3.2.2. Regarding ECG
All troponin +ve patients showed abnormal ECG (100%),
compared to only 26 patients out of the troponin ve patients
(27%), P< 0.01. ST deviation occurred in 10 troponin +veTable 1 Risk factors among the study group.
No. %
Hypertension 60 50
Current smokers 58 48.3
Dyslipidemia 52 43.3
Diabetes 28 23.3
Table 2 ECG changes and echocardiographic data among the
study group.
No. %
ST deviation 12 10
T 38 31.6
AF 6 5
RBBB 1 0.83
SWMA 24 20
Table 3 Comparison between troponin +ve patients and troponin
Troponin +ve (24)
No. %
Gender M 14 58.33
F 10 41.67
Diabetes 8 33.33
Smoker 12 50
Dyslipedemia 18 75
Hypertension 24 100patients (41.6%) and 2 troponin ve patients (2.08%),
P< 0.01. T wave changes occurred in 14 troponin +ve pa-
tients (58.3%) and 24 troponin ve patients (25%),
P< 0.05 (Fig. 1).
3.2.3. Regarding echocardiography
Resting SWMA were observed in 24 cases, all of which had
+ve troponin while none of the troponin ve patients showed
SWMA, p< 0.0001. According to the predeﬁned criteria, tro-
ponin had 100% sensitivity, speciﬁcity, positive and negative
predictive values for SWMA (Fig. 1).
3.2.4. Regarding cerebral lesion
Mean volume of the cerebral lesion was signiﬁcantly higher in
troponin +ve patients compared to that in troponin ve pa-
tients. The diameter of the lesion was signiﬁcantly larger in tro-
ponin +ve patients. Small to moderate lesions were observed
in the majority of the troponin ve patients (97.9%), while
large lesions were present in most of the troponin +ve patients
(75%) (Tables 4 and 5). No signiﬁcant differences were noted
in troponin +ve patients regarding the underlying pathology.
CTNT was +ve in 12 patients with infarction and 12 patients
with hemorrhage p> 0.05.
4. Discussion
Acute cerebrovascular insults may induce cardiac changes
even in patients without coronary artery disease.16 Cardiac
damage in acute stroke has been studied by measuring cre-
atine kinase myocardial band (CK-MB) or by autopsy.
These studies lacked neuroimaging conﬁrmation of stroke.
Neurological injury can produce ECG changes, cardiac dys-
function, and focal cardiac injury.17 Such changes are well
characterized after subarachnoid hemorrhage and head trau-
ma.16 Previous studies17–20; of serum markers of myocardial
injury in acute stroke did not include neuroimaging conﬁr-
mation of stroke, or CTNT determination, unlike the pres-
ent study. Myocardial injury after stroke or other acute
cerebral lesions was attributed to abnormally high levels of
plasma catecholamine secondary to rapidly increasing intra-
cranial pressure.21 Currently cardiac troponins are consid-
ered the most accurate biomarker of myocardial injury in
the clinical setting.
In the current study, 120 patients with acute CVS were
studied using the troponin T assay. One ﬁfth of the stroke pa-
tients had elevated CTNT. James et al.7 reported elevated
CTNT in about 17% of their samples, while Julio A. Chalela
et al.18 reported elevated CTNT in 6%.ve patients regarding sex and risk factors.
Troponin -ve (96) P
No. %
56 58.33 NS
40 41.67
20 20.93 NS
46 47.92 NS
34 35.42 <0.05
36 37.5 <0.01
Figure 1 ST-T wave abnormalities and SWMA in troponin +ve
and troponin ve patients.
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tension and dyslipedemia in stroke patients with elevated
troponin levels versus stroke patients with normal troponin
levels. This may give a good explanation to the occurrence
of myocardial injury in these possibly due to the presence of
more vulnerable coronary plaques. We also suggest that some
risk factors may carry the power to prepare myocardial vascu-
lature to the harmful effect of the released catecholamines
(stress myocardial injury).
4.1. ECG ﬁndings among stroke patients with elevated troponin
levels versus patients with normal levels
Earlier studies reported contradictory ﬁndings about the ST-T
changes observed in acute stroke patients.22 They detected ST
changes in 26.31% of patients and T changes in 28%. Others
reported ST changes in 39–50% and T wave changes in 25–
50% of patients.19 In this study, we demonstrated signiﬁcant
differences regarding ST-T wave, between stroke patients with
elevated troponin levels versus stroke patients with normal tro-
ponin levels. Although the majority of the previous studies sta-
ted that the ST-T changes in these patients are non speciﬁc,23Table 4 Comparison between troponin +ve patients and troponin 
Troponin T +e (24) T
Mean ± SD M
Volume (cm3) 96.92 ± 16.3 28
Diameter (cm) 3.83 ± 0.58 2.
Table 5 Comparison between troponin +ve patients and troponin
Troponin T +ve (24) Tro
No. % No
Small 6 25 94
Large 18 75 2the correlation between elevated CTNT levels and echocardio-
graphic abnormalities in this study and other studies may give
us a clue that these ST-T abnormalities were due to myocardial
ischemia or/and injury.24
4.2. Echocardiographic results among stroke patients with
elevated troponin levels versus patients with normal levels
The current study showed a signiﬁcant difference in wall mo-
tion abnormalities between stroke patients with elevated tro-
ponin levels versus stroke patients with normal levels. All
(100%) patients with elevated troponin levels had segmental
wall motion abnormalities. Several studies reported a signiﬁ-
cant correlation between echocardiographic changes and
CTNT levels.25–27 Moreover, a signiﬁcant inverse correlation
was reported between elevated CTNT levels and LV ejection
fraction.27
4.3. Stroke volume and its relation to elevated CTNT levels
This study showed a signiﬁcant positive correlation between
elevated CTNT levels and increased volume of the cerebral le-
sion as demonstrated via CT scan. Similar ﬁndings were re-
ported by Apak et al.26 and Panteghini et al.27 This may be
explained by the amount of catecholamine release (surge),
which is possibly directly correlated to the size of the cerebral
lesion.5. Conclusions
Myocardial injury is not uncommon in patients with CVS.
Myocardial injury was demonstrated in one ﬁfth of the pa-
tients of this study. Silent ST-T wave changes and new rest-
ing SWMA are possible complications. CTNT is a sensitive
marker in detecting myocardial injury after cerebral stroke
that also correlates with the size of the cerebral lesion. Mea-
surement of the serum level of CTNT may provide a useful
aid in estimating the volume of stroke lesion and possibly
the prognosis of the stroke in clinical practice. Future ther-
apies may be directed toward preventing cardiac events in
CVS patients, thereby reducing overall morbidity and
mortality.ve patients regarding volume and diameter of the cerebral lesion.
roponin T ve (96) T P
ean ± SD
.71 ± 11.45 16.88 <0.001
46 ± 0.62 6.98 <0.001
ve patients regarding severity of cerebral lesion.
ponin T ve (96) v2 P
. %
97.92 36.75 <0.001
2.08
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